MedPath
NMPA Approval

Compound Lysine Granules

国药准字H20013337

September 20, 2020

国药准字H20013337

Drug Information

复方赖氨酸颗粒

邕江

颗粒剂

3g

化学药品

September 20, 2020

Company Information

Applicant Company

南宁市白沙大道100号

Manufacturing Company

南宁市白沙大道100号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方赖氨酸颗粒 - NMPA 批准文号 | MedPath